HOGY MEDICAL Delisting May 15, 2026, Reverse Stock Split
Summary
Tokyo Stock Exchange designated HOGY MEDICAL CO.,LTD. (Code: 3593, Prime Market) as Securities to Be Delisted effective April 24, 2026, with the final delisting scheduled for May 15, 2026. The delisting was triggered by shareholder approval of a reverse stock split at a ratio where shares held by non-specified parties would be less than one share, falling under Securities Listing Regulations Rule 601, Paragraph 1, Item (18). The stock will be excluded from securities in lieu of money for margin transactions, when-issued trading, and participant security starting April 27, 2026.
“TSE has decided on delisting and designation as Securities to Be Delisted as follows.”
About this source
GovPing monitors Japan Exchange Group for new securities & markets regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 18 changes logged to date.
What changed
TSE has formally designated HOGY MEDICAL CO.,LTD. for delisting following shareholder approval of a reverse stock split at a ratio that would render non-specified shareholders' holdings fractional. The designation period runs from April 24 to May 14, 2026, with the final delisting effective May 15, 2026.\n\nInvestors holding HOGY MEDICAL shares should note that trading will cease on May 15, 2026, and the stock becomes ineligible for use as collateral or margin security starting April 27, 2026. The company falls under Rule 601 automatic delisting criteria due to the reverse split structure.
Archived snapshot
Apr 24, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Apr. 24, 2026 TSE Decision on Delisting, etc.: HOGY MEDICAL CO.,LTD.
Post TSE has decided on delisting and designation as Securities to Be Delisted as follows.
１．Delisting and Designation as Securities to Be Delisted
| （１）Issue Name | HOGY MEDICAL CO.,LTD. stock
(Code: 3593, Market Segment: Prime Market) |
| （２）Period of Designation as
Securities to Be Delisted | From Apr. 24, 2026 (Fri.) to May 14, 2026 (Thu.) |
| （３）Delisting Date | May 15, 2026 (Fri.)
(Note) In cases where circumstances in which the company should be promptly delisted occur, TSE may change the period of designation as Securities to Be Delisted and the delisting date. |
| （４）Reason
(Related Clause) | Due to falling under a case where the company implements a reverse stock split with a split ratio at which the number of all the shares owned by shareholders other than a specified party will be less than one share
(Securities Listing Regulations, Rule 601, Paragraph 1, Item (18)) |
| （５）Details of Reason | At the general shareholders meeting of HOGY MEDICAL CO.,LTD. (hereinafter "the Company") held today, the agenda item regarding a reverse stock split with a split ratio at which each of the shares held by shareholders other than specified entities will be less than one share was approved. |
２．Exclusion from Securities in Lieu of Money
The stock of the Company will be excluded from securities in lieu of money for the following items from Apr. 27, 2026 (Mon.) inclusive.
- Customer margin for margin transactions and when-issued transactions
- Trading margin for when-issued transactions
- Trading participant security money
- Participant bonds
Current Designations of Securities Under Supervision & Securities to Be Delisted
Designation History of Securities Under Supervision & Securities to Be Delisted DISCLAIMER: This translation may be used for reference purposes only. This English version is not an official translation of the original Japanese document. In cases where any differences occur between the English version and the original Japanese version, the Japanese version shall prevail. This translation is subject to change without notice. Tokyo Stock Exchange, Inc. and/or Japan Exchange Regulation shall individually or jointly accept no responsibility or liability for damage or loss caused by any error, inaccuracy, misunderstanding, or changes with regard to this translation.
Enquiry
Tokyo Stock Exchange, Inc. Listing Department, Corporate Disclosure Office, Planning & Coordination, Listed Company Services
TEL:+81-3-3666-0141(Switchboard)
Named provisions
Parties
Related changes
Get daily alerts for Japan Exchange Group
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from JPX.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when Japan Exchange Group publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.